Works matching IS 15228517 AND DT 2024 AND VI 26 AND IP 3
Results: 23
A valuable glioblastoma prognostic marker driven by radiosensitivity.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 592, doi. 10.1093/neuonc/noae010
- Publication type:
- Article
Understanding the mechanisms of diffuse midline glioma cell migration toward therapeutic targeting.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 569, doi. 10.1093/neuonc/noad263
- By:
- Publication type:
- Article
Management of sporadic intracanalicular vestibular schwannomas: A critical review and International Stereotactic Radiosurgery Society (ISRS) practice guidelines.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 429, doi. 10.1093/neuonc/noad253
- By:
- Publication type:
- Article
The potential of amino acid PET imaging for prediction and monitoring of vorasidenib response in IDH-mutant gliomas.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 403, doi. 10.1093/neuonc/noad240
- By:
- Publication type:
- Article
Nuclear translocation matters: Role of FABP7 in driving glioblastoma stemness and invasion: Reply to Mu et al.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 590, doi. 10.1093/neuonc/noad239
- By:
- Publication type:
- Article
Polyunsaturated fatty acid-binding protein FABP7, an attractive metabolic target for inhibition of glioblastoma stem cells.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 587, doi. 10.1093/neuonc/noad238
- By:
- Publication type:
- Article
Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 584, doi. 10.1093/neuonc/noad237
- By:
- Publication type:
- Article
The impact of the COVID-19 pandemic on treatment patterns in glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 581, doi. 10.1093/neuonc/noad234
- By:
- Publication type:
- Article
Measure what is measurable: PET RANO 1.0 criteria for interpretation of amino acid PET of diffuse gliomas.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 401, doi. 10.1093/neuonc/noad228
- By:
- Publication type:
- Article
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 407, doi. 10.1093/neuonc/noad227
- By:
- Publication type:
- Article
Walking the tightrope between DNA damage repair and genomic integrity.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 399, doi. 10.1093/neuonc/noad218
- By:
- Publication type:
- Article
Emotion recognition in relation to tumor characteristics in patients with low-grade glioma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 528, doi. 10.1093/neuonc/noad209
- By:
- Publication type:
- Article
Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 488, doi. 10.1093/neuonc/noad208
- By:
- Publication type:
- Article
Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high-grade glioma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 538, doi. 10.1093/neuonc/noad207
- By:
- Publication type:
- Article
The role of minimally invasive surgery within a multidisciplinary approach for patients with metastatic spine disease over a decade: A systematic review.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 417, doi. 10.1093/neuonc/noad206
- By:
- Publication type:
- Article
Systematic characterization of antibody–drug conjugate targets in central nervous system tumors.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 458, doi. 10.1093/neuonc/noad205
- By:
- Publication type:
- Article
Frequencies of 4 tumor-infiltrating lymphocytes potently predict survival in glioblastoma, an immune desert.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 473, doi. 10.1093/neuonc/noad204
- By:
- Publication type:
- Article
Added prognostic value of 3D deep learning-derived features from preoperative MRI for adult-type diffuse gliomas.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 571, doi. 10.1093/neuonc/noad202
- By:
- Publication type:
- Article
Single-cell transcriptomes reveal the heterogeneity and microenvironment of vestibular schwannoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 444, doi. 10.1093/neuonc/noad201
- By:
- Publication type:
- Article
Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 503, doi. 10.1093/neuonc/noad197
- By:
- Publication type:
- Article
Telehealth group Cognitive–Behavioral Therapy for Insomnia (CBT-I) in primary brain tumor: Primary outcomes from a single-arm phase II feasibility and proof-of-concept trial.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 516, doi. 10.1093/neuonc/noad193
- By:
- Publication type:
- Article
Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 3, p. 553, doi. 10.1093/neuonc/noad161
- By:
- Publication type:
- Article